Wang Zhenna, Xie Yi, Mao Yanhui, Yan Shihan, Huang Jingyu, Lin Shunhe
Zhenna Wang Department of Obstetrics and Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology Pediatrics, Fujian Medical University, Fuzhou, Fujian Province 350001, P.R. China.
Yi Xie Department of Obstetrics and Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology Pediatrics, Fujian Medical University, Fuzhou, Fujian Province 350001, P.R. China.
Pak J Med Sci. 2025 Jan;41(1):55-63. doi: 10.12669/pjms.41.1.11145.
To investigate the correlation between endometriosis (EMs) severity and placenta accreta spectrum (PAS) risk in the subsequent pregnancy.
Clinical records of 2,142 patients who underwent laparoscopic surgery for EMs at Fujian Provincial Maternal and Child Health Hospital from January 2014 to January 2018, who had achieved pregnancy and were delivered, were analyzed. Baseline data, EMs stage, The Revised American Fertility Society (R-AFS) score, levels of serum indexes, and pregnancy and neonatal outcomes were recorded. The outcome of interest was the occurrence of PAS. The correlation between the R-AFS score, endometriosis staging, and PAS was explored, and the R-AFS threshold was identified.
PAS was associated with a higher incidence of chronic pelvic pain (OR = 8.68, 95% CI: 1.18-45.79, P = 0.014) and infertility for >five years (OR = 2.5, 95% CI: 1.35-4.65, P = 0.003), elevated serum levels of cancer antigens, higher incidence of postpartum hemorrhage, and placenta previa (P < 0.05). PAS rate was higher in women with higher EMs staging and R-AFS score and ovarian EMs combined with deep infiltrating endometriosis (DIE) (P < 0.001). After adjusting for confounders, both R-AFS score (AOR = 1.02, 95% CI: 1.01-1.03, P < 0.001) and ovarian EMs with DIE (AOR = 3.31, 95% CI: 1.54-6.67, P = 0.001) were independent risk factors for PAS. R-AFS score of 29 was identified as a threshold for an increased risk of PAS.
The risk of PAS in patients with endometriosis increases with the R-AFS score. PAS is more likely to occur in women with ovarian EMs combined with DIE. It is necessary to implement a specific monitoring program during pregnancy in patients with a history of severe EMs.
探讨子宫内膜异位症(EMs)严重程度与后续妊娠中胎盘植入谱系疾病(PAS)风险之间的相关性。
分析2014年1月至2018年1月在福建省妇幼保健院因EMs接受腹腔镜手术、已妊娠并分娩的2142例患者的临床记录。记录基线数据、EMs分期、美国生殖医学协会修订版(R-AFS)评分、血清指标水平以及妊娠和新生儿结局。感兴趣的结局是PAS的发生情况。探讨R-AFS评分、子宫内膜异位症分期与PAS之间的相关性,并确定R-AFS阈值。
PAS与慢性盆腔痛发生率较高(OR = 8.68,95%CI:1.18 - 45.79,P = 0.014)、不孕超过5年(OR = 2.5,95%CI:1.35 - 4.65,P = 0.003)、血清癌抗原水平升高、产后出血发生率较高以及前置胎盘相关(P < 0.05)。EMs分期和R-AFS评分较高以及卵巢EMs合并深部浸润性子宫内膜异位症(DIE)的女性PAS发生率更高(P < 0.001)。在调整混杂因素后,R-AFS评分(AOR = 1.02,95%CI:1.01 - 1.03,P < 0.001)和卵巢EMs合并DIE(AOR = 3.31,95%CI:1.54 - 6.67,P = 0.001)均为PAS的独立危险因素。R-AFS评分为29被确定为PAS风险增加的阈值。
子宫内膜异位症患者发生PAS的风险随R-AFS评分升高而增加。PAS更易发生于卵巢EMs合并DIE的女性。对于有重度EMs病史的患者,孕期有必要实施特定的监测方案。